I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Langley, RG
10
results:
Search for persons
X
Format
Online (10)
Mediatypes
Articles (Online) (3)
OpenAccess-fulltext (7)
Sorted by: Relevance
Sorted by: Year
?
1
Bimekizumab infection rates in patients with moderate to se..:
Armstrong, A
;
Langley, RG
;
Gordon, KB
...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 6 - p. s72 , 2022
Link:
https://doi.org/10.25251..
?
2
Bimekizumab versus secukinumab continuous maintenance of re..:
Warren, RB
;
Conrad, C
;
Foley, P
...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 6 - p. s70 , 2022
Link:
https://doi.org/10.25251..
?
3
Dose Response and Pharmacokinetics of Tofacitinib (CP‐690,5..:
Tan, H
;
Gupta, P
;
Harness, J
...
CPT: Pharmacometrics & Systems Pharmacology. 2 (2013) 5 - p. 1-8 , 2013
Link:
https://doi.org/10.1038/..
?
4
Five-year efficacy and safety of tildrakizumab in patients ..:
Thaci, D
;
Piaserico, S
;
Warren, RB
...
issn:0007-0963. , 2021
Link:
http://hdl.handle.net/11..
?
5
Efficacy of adalimumab across subgroups of patients with mo..:
Poulin, Y
;
Crowley, JJ
;
Langley, RG
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014
Link:
http://www.ncbi.nlm.nih...
?
6
Dose Response and Pharmacokinetics of Tofacitinib (CP-690,5..:
Tan, H
;
Gupta, P
;
Harness, J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674331. , 2013
Link:
http://www.ncbi.nlm.nih...
?
7
A randomized, double-blind, placebo-controlled study to eva..:
Gottlieb, AB
;
Langley, RG
;
Strober, BE
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504074. , 2012
Link:
http://www.ncbi.nlm.nih...
?
8
Bimekizumab infection rates in patients with moderate to se..:
A Armstrong
;
RG Langley
;
KB Gordon
...
url:https://www.openaccessrepository.it/communities/itmirror. , 2022
Link:
https://www.openaccessre..
?
9
Antarctic Bedmap data: Findable, Accessible, Interoperable,..:
Frémand, AC
;
Fretwell, P
;
Bodart, JA
...
orcid:0000-0002-0090-4806 (Siegert, MJ). , 2023
Link:
http://hdl.handle.net/10..
?
10
Improving the oral health of older people in care homes (TO..:
Tsakos, G
;
Brocklehurst, PR
;
Watson, S
...
https://discovery.ucl.ac.uk/id/eprint/10131903/1/s40814-021-00872-6.pdf. , 2021
Link:
https://discovery.ucl.ac..
1-10
